Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Banks, IT buoy markets
Wed, 23 Dec 12:30 pm

After witnessing a strong start to the day's trades, Indian stock markets gained further ground on sustained buying activity during previous two hours of trade. Currently, stocks from the energy, IT, and power sectors are leading the pack of gainers.

The BSE Sensex and NSE Nifty are trading in the green, up by around 400 points and 105 points respectively. Mid and small-cap stocks too are fueling the buoyancy. The BSE Midcap and BSE Smallcap indices are trading up by 1.2% and 1.5% respectively. The rupee is trading at 46.85 to the dollar.

As per a leading business daily, pharmaceutical major Lupin has settled all its patent litigations relating to its US launch of a copy version of the 'memantine tablets' which are patented by the multinational pharma company Forest Laboratories Inc. The company has not disclosed the settlement amount it has paid for this drug, which is used to treat Alzheimer's Syndrome. However, as per the terms of the settlement, Lupin will be licensed to commercially launch its version in January 2015, or even earlier under special circumstances. It may be noted that Lupin's generic version has been approved by the US Food and Drug Administration under Para 4 provision. Forest Labs sells the drug under the brand name Namenda. The company generated sales of US$ 949 m from this drug in the year 2008 and it accounted for 26% of Forest Labs' sales during the year. The stock of Lupin is trading higher on the bourses currently.

As per a leading business daily, ONGC's overseas subsidiary ONGC Videsh (OVL) has raised Rs 19.7 bn (US$ 420 m) via an issuance of bonds. These bonds have been issued by the company with an 8.4% coupon rate and have a five-year maturity. The bonds have been rated 'AAA' by rating agency Crisil and carry a guarantee from OVL's parent ONGC. It may be noted that OVL had earlier this year raised Rs 50 bn by way of 1 year commercial paper. The company's management was looking to refinance OVL's debt. Thus this bond issuance will help the company refinance some of these outstanding rupee borrowings it had taken for its overseas acquisition of Imperial Energy Corp PLC last year. Energy stocks are trading higher with ONGC and RIL both witnessing gains currently.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Banks, IT buoy markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.